The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 29, 2016
Filed:
Feb. 03, 2012
Applicants:
Michael Freissmuth, Vienna, AT;
Christina Gloeckel, Vienna, AT;
Xaver Koenig, Vienna, AT;
Simon Keuerleber, Vienna, AT;
Inventors:
Michael Freissmuth, Vienna, AT;
Christina Gloeckel, Vienna, AT;
Xaver Koenig, Vienna, AT;
Simon Keuerleber, Vienna, AT;
Assignee:
SciPharm SaRL, Junglinster, LU;
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); C07K 14/47 (2006.01); A01N 37/10 (2006.01); A61K 31/19 (2006.01); A61K 31/192 (2006.01); A61K 31/4166 (2006.01); A61K 31/437 (2006.01); A61K 31/44 (2006.01); A61K 31/5575 (2006.01); A61K 31/5578 (2006.01); A61K 31/5585 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/192 (2013.01); A61K 31/4166 (2013.01); A61K 31/437 (2013.01); A61K 31/44 (2013.01); A61K 31/5575 (2013.01); A61K 31/5578 (2013.01); A61K 31/5585 (2013.01); A61K 45/06 (2013.01);
Abstract
The present invention provides a composition comprising at least one prostacyclin or prostacyclin analog or a pharmaceutically acceptable salt thereof and at least one phosphodiesterase (PDE) 4 inhibitor and optionally a further PDE inhibitor for use in preventing or treating cystic fibrosis by selectively increasing the cAMP levels in bronchoepithelial cells.